GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » Gross-Profit-to-Asset %

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Gross-Profit-to-Asset % : 72.58% (As of Dec. 2013)


View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Nobel Biocare Holding AG's annualized Gross Profit for the quarter that ended in Dec. 2013 was $589.5 Mil. Nobel Biocare Holding AG's average Total Assets over the quarter that ended in Dec. 2013 was $812.1 Mil. Therefore, Nobel Biocare Holding AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2013 was 72.58%.


Nobel Biocare Holding AG Gross-Profit-to-Asset % Historical Data

The historical data trend for Nobel Biocare Holding AG's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG Gross-Profit-to-Asset % Chart

Nobel Biocare Holding AG Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.35 57.15 63.25 73.57 72.58

Nobel Biocare Holding AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.35 57.15 63.25 73.57 72.58

Competitive Comparison of Nobel Biocare Holding AG's Gross-Profit-to-Asset %

For the Medical Instruments & Supplies subindustry, Nobel Biocare Holding AG's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nobel Biocare Holding AG's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nobel Biocare Holding AG's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Nobel Biocare Holding AG's Gross-Profit-to-Asset % falls into.



Nobel Biocare Holding AG Gross-Profit-to-Asset % Calculation

Nobel Biocare Holding AG's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2013 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2013 )/( (Total Assets (A: Dec. 2012 )+Total Assets (A: Dec. 2013 ))/ count )
=589.477/( (788.762+835.514)/ 2 )
=589.477/812.138
=72.58 %

Nobel Biocare Holding AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2013 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2013 )/( (Total Assets (Q: Dec. 2012 )+Total Assets (Q: Dec. 2013 ))/ count )
=589.477/( (788.762+835.514)/ 2 )
=589.477/812.138
=72.58 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (Dec. 2013) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Nobel Biocare Holding AG Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Traded in Other Exchanges
N/A
Address
Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines